Group Introduction Home > Introduction > Group Introduction
  Chongqing Fuan Pharmaceutical (Group) Co., Ltd. was established in February 25, 2004, the company is located in Chongqing Changshou Economic and Technological Development Zone, Economic and Technological Development Zone is the longevity of the first construction, the first production of the modern pharmaceutical companies, covers an area of about 100 mu, building area of more than 20,000 square meters, registered capital of 1.7342 million yuan. March 22, 2011, the Company successfully listed on the Shenzhen Stock Exchange GEM (Stock Code: 300194).
  The company owns five wholly owned and controlled subsidiaries, namely: March 2008 establishment engaged in pharmaceutical research and development, a wholly owned subsidiary of Chongqing Fuan Pharmaceutical Group at the State Drug Development Limited, in July 2009 to a wholly-owned acquisitions preparation of production for the main business in Chongqing Fuan Pharmaceutical Group Qingyu Tang Pharmaceutical Co., Ltd. and is principally engaged in pharmaceutical sales Biological Products Co., Ltd. in Chongqing, in August 2011, a wholly owned production in preparation for the main business of the Hubei People Pharmaceutical Co., company, in October 2011 in the production of pharmaceutical intermediates holding wide-NKT Chemical Co., Ltd.. The company has been formed from the drug development to pharmaceutical intermediates, bulk drugs, formulations production, to product sales of a complete industrial chain.
  The company has two state-level key new products, won the National Torch Plan Key High-tech enterprises, the national high-tech enterprises; possess Chongqing key outstanding new product 2, Chongqing key new product 11 in Chongqing High-tech products 8, technological innovation projects 4, won the Chongqing Municipal Enterprise Technology Center, Engineering Research Center of anticancer drugs, undertake a number of research topics in Chongqing, 25 applications for invention patents, license 9.
  The company mainly engaged in chemical raw materials and preparations for production and sales. The company mainly involved in the areas of anti-infective, anti-tumor, mental nervous system, cardiovascular, digestive, endocrine and metabolic, skeletal and muscular systems.
  To build the company into the largest supplier of raw materials, the company is committed to long-term sustainable development, in a responsible manner to carry out business activities, and efforts to contribute to the prosperity of society. Has been formed to Beijing, Shanghai, Guangdong, Hebei, Hainan, Jiangsu, Sichuan, Hunan, more than ten municipalities, provincial and municipal-based product sales network. We are dedicated to providing the best products and high standards of service, integrity and attitude with customers to establish long-term and stable partnership.
  To broaden the sales channels, the company has made progress in 2006 produced franchise, and actively carry out cooperation with foreign customers. The company has established a strict quality assurance system and EHS management system, according to the cGMP management, and can provide CTD-DMF file support, to the United States, the EU regulatory requirements regulating the market, with many countries, the establishment of close cooperation.
  Group company has more than 1,000 employees, of whom more than 14 master's and master's, bachelor degree or above 180 people, talent echelon and reasonable structure. The company has "dedicated, professional, concentrate on doing drugs to the public well-being of its mission, maximize shareholder" business purpose, adhere to the "people-oriented, technology first, innovation is the soul, the pursuit of excellence" business philosophy. "Twelve Five" period, the company will actively promote the optimization of product structure, accelerate product development and industrialization of scientific research efforts to complete antibiotic products dominated by the antibiotics and medicines to the joint development of the strategic adjustment of the company's future development lay a solid foundation.

Contacts: Tian Xiangqin

Tel: 0086 23 61218100

Email: xiangqin.tian@fapharm.com


Contacts: Wu Yu

Tel: 0086 23 61028787

Email: fuanpharm@126.com

Add:No 2,Huang Yang Road,Yu Bei District,Chongqiang,China